Abstract
Pathogenic fungi are a major causative group for opportunistic infections (OIs). AIDS patients and other immunocompromised individuals are at risk for OIs, which if not treated appropriately, contribute to the mortality associated with their conditions. Several studies have indicated that the majority of HIV-positive patients contract fungal infections throughout the course of their disease. Similar observations have been made regarding the increased frequency of bone marrow and organ transplants, the use of antineoplastic agents, the excessive use of antibiotics, and the prolonged use of corticosteroids among others. In addition, several pathogenic fungi have developed resistance to current drugs. Together these have conspired to spur a need for developing new treatment options for OIs. To aid this effort, this article reviews the biological targets of current and emerging drugs and agents that act through these targets for the treatment of opportunistic fungal infections.
Keywords: Antifungal agents, Antifungal drug target, Anti-opportunistic infection, Biological target, Fungal infections, Mechanism of action, Opportunistic infection targets, Target of antifungal agents.
Mini-Reviews in Medicinal Chemistry
Title:The Mechanistic Targets of Antifungal Agents: An Overview
Volume: 16 Issue: 7
Author(s): Tryphon K. Mazu, Barbara A. Bricker, Hernan Flores-Rozas and Seth Y. Ablordeppey
Affiliation:
Keywords: Antifungal agents, Antifungal drug target, Anti-opportunistic infection, Biological target, Fungal infections, Mechanism of action, Opportunistic infection targets, Target of antifungal agents.
Abstract: Pathogenic fungi are a major causative group for opportunistic infections (OIs). AIDS patients and other immunocompromised individuals are at risk for OIs, which if not treated appropriately, contribute to the mortality associated with their conditions. Several studies have indicated that the majority of HIV-positive patients contract fungal infections throughout the course of their disease. Similar observations have been made regarding the increased frequency of bone marrow and organ transplants, the use of antineoplastic agents, the excessive use of antibiotics, and the prolonged use of corticosteroids among others. In addition, several pathogenic fungi have developed resistance to current drugs. Together these have conspired to spur a need for developing new treatment options for OIs. To aid this effort, this article reviews the biological targets of current and emerging drugs and agents that act through these targets for the treatment of opportunistic fungal infections.
Export Options
About this article
Cite this article as:
Mazu K. Tryphon, Bricker A. Barbara, Flores-Rozas Hernan and Ablordeppey Y. Seth, The Mechanistic Targets of Antifungal Agents: An Overview, Mini-Reviews in Medicinal Chemistry 2016; 16 (7) . https://dx.doi.org/10.2174/1389557516666160118112103
DOI https://dx.doi.org/10.2174/1389557516666160118112103 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Connexins, Diabetes and the Metabolic Syndrome
Current Protein & Peptide Science Use of Artificial Cell Microcapsule Containing Thalidomide for Treating TNBS-induced Crohn's Disease in Mice
Current Drug Delivery Short Peptide Modules for Enhancing Intestinal Barrier Function
Current Pharmaceutical Design Mesenchymal Stem Cells Derived from Wharton's Jelly of the Umbilical Cord: Biological Properties and Emerging Clinical Applications
Current Stem Cell Research & Therapy Management of Complicated Pneumonia in Childhood: A Review of Recent Literature
Reviews on Recent Clinical Trials Targeting Ras Activity Prevented Amyloid Beta-Induced Aberrant Neuronal Cell Cycle Re-Entry and Death
Current Alzheimer Research Bioactive N-Phenylimidazole Derivatives
Current Chemical Biology Involvement of Cytosolic Phospholipase A2, Calcium Independent Phospholipase A2 and Plasmalogen Selective Phospholipase A2 in Neurodegenerative and Neuropsychiatric Conditions
Current Medicinal Chemistry <i>In silico</i> Analysis of <i>Plasmodium falciparum</i> Actin and Profilin Interaction at the Interface Region for Antimalarial Drug Designing
Letters in Drug Design & Discovery Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy
Current Angiogenesis (Discontinued) Defective Autophagy in Fibroblasts May Contribute to Fibrogenesis in Autoimmune Processes
Current Pharmaceutical Design Surface Chemistry Influences Implant Biocompatibility
Current Topics in Medicinal Chemistry Ameliorative Role of Green Tea and Zinc Oxide Nanoparticles Complex Against Monosodium Glutamate-Induced Testicular Toxicity in Male Rats
Current Pharmaceutical Biotechnology Occurrence, Functions and Biological Significance of Arginine-Rich Proteins
Current Protein & Peptide Science Specific Targeted Therapy: A New Tool for the Destruction of Cancer
Current Drug Therapy Herpes Labialis: An Update
Recent Patents on Inflammation & Allergy Drug Discovery Improved Anti-Tumor Activity of Novel Highly Bioactive Liposome-Bound TRAIL in Breast Cancer Cells
Recent Patents on Anti-Cancer Drug Discovery Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Current Pharmaceutical Design Development and Characterization of a Clobetasol Propionate Nanostructured Lipid Carrier-Based Gel for the Treatment of Plaque Psoriasis
Current Molecular Pharmacology SUBJECT INDEX TO VOLUME 1
Current Drug Targets